← Leaderboards
Cynthia K Miranti
Van Andel Research Institute
$3,405,241
Attributed
$4,729,861
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $526.4K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,729,861 · 6
By mechanism
R01$4,275,809 · 2
R41$300,000 · 1
P30$141,052 · 1
R13$13,000 · 2
Top collaborators
- Yitshak Zohar5 shared
- Laurence H Hurley1 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsSignal TransductionCancer CellNeoplastic CellMouse ModelCellsProstateMalignant Neoplasm Of ProstateTissuesIn VivoTumorCell LineOncogenesPhenotypePre-ClinicalPublishingSignal PathwayHuman TissueEpithelial CellsAndrogen ReceptorDiagnosisEnvironmentCell SurvivalClinical Trials
Grant awards (20)
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer$472,861
R01 · FY2025 · CA · contact PI
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer$451,639
R01 · FY2024 · CA · contact PI
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer$468,397
R01 · FY2023 · CA · contact PI
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer$472,143
R01 · FY2022 · CA · contact PI
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer$484,200
R01 · FY2021 · CA · contact PI
Program 3: Cancer BiologyProgram (CBP)$42,168
P30 · FY2021 · CA · contact PI
Program 3: Cancer BiologyProgram (CBP)$32,142
P30 · FY2020 · CA · contact PI
Program 3: Cancer BiologyProgram (CBP)$32,581
P30 · FY2019 · CA · contact PI
Program 3: Cancer BiologyProgram (CBP)$22,222
P30 · FY2019 · CA · contact PI
Program 3: Cancer BiologyProgram (CBP)$11,939
P30 · FY2019 · CA · contact PI
DNA Quadruplex Control of hTERT Transcription: A New Therapy for Taxotere Resistant Prostate Cancer$300,000
R41 · FY2018 · CA
Tetraspanin Scaffolds as Targets and Markersof Cancer and Infectious Disease$5,000
R13 · FY2018 · CA · contact PI
Role of alpha6 beta1 Integrin in Prostate Cancer$347,376
R01 · FY2017 · CA · contact PI
Role of alpha6 beta1 Integrin in Prostate Cancer$34,530
R01 · FY2016 · CA · contact PI
Role of alpha6 beta1 Integrin in Prostate Cancer$381,906
R01 · FY2015 · CA · contact PI
Role of alpha6 beta1 Integrin in Prostate Cancer$370,449
R01 · FY2014 · CA · contact PI
Role of alpha6 beta1 Integrin in Prostate Cancer$380,142
R01 · FY2013 · CA · contact PI
Role of alpha6 beta1 Integrin in Prostate Cancer$77,096
R01 · FY2013 · CA · contact PI
Role of alpha6 beta1 Integrin in Prostate Cancer$335,070
R01 · FY2012 · CA · contact PI
Tyrosine Kinase Signaling in Cancer, Disease, & Development$8,000
R13 · FY2012 · CA · contact PI